Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-04-03

FDA Approved: BACLOFEN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for Baclofen (BACLOFEN), updating the existing approval for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)